Coronavirus: FDA advisory panel recommends use of Pfizer vaccine

This story is published in a content partnership with POLITICO. It was originally reported by Sarah Owermohle and Zachary Brennan on politico.com on December 10, 2020.An independent FDA advisory committee said that the benefits of Pfizer‘s coronavirus vaccine outweigh the risks, setting the stage for the agency to authorise emergency use of the shot for people 16 and older.The panel – comprising academic scientists, doctors and officials from other federal health agencies – voted 17 to 4 in…

Read the original article at South China Morning Post